MDxHealth SA (MDXH)
Total Valuation
MDxHealth has a market cap or net worth of $70.68 million. The enterprise value is $155.72 million.
Market Cap | 70.68M |
Enterprise Value | 155.72M |
Important Dates
The last earnings date was Wednesday, March 6, 2024, after market close.
Earnings Date | Mar 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MDxHealth has 27.29 million shares outstanding.
Shares Outstanding | 27.29M |
Owned by Insiders (%) | 2.63% |
Owned by Institutions (%) | 40.30% |
Float | 17.00M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.01 |
Forward PS | 0.87 |
PB Ratio | 9.81 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.22 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.96, with a Debt / Equity ratio of 14.90.
Current Ratio | 1.96 |
Quick Ratio | 1.71 |
Debt / Equity | 14.90 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1.73 |
Financial Efficiency
Return on equity (ROE) is -192.90% and return on invested capital (ROIC) is -23.84%.
Return on Equity (ROE) | -192.90% |
Return on Assets (ROA) | -30.90% |
Return on Capital (ROIC) | -23.84% |
Revenue Per Employee | $278,544 |
Profits Per Employee | -$171,032 |
Employee Count | 252 |
Asset Turnover | 0.50 |
Inventory Turnover | 10.29 |
Taxes
In the past 12 months, MDxHealth has paid $1,000 in taxes.
Income Tax | 1,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.52% in the last 52 weeks. The beta is -379,681.88, so MDxHealth's price volatility has been lower than the market average.
Beta (1Y) | -379,681.88 |
52-Week Price Change | -14.52% |
50-Day Moving Average | 3.38 |
200-Day Moving Average | 3.29 |
Relative Strength Index (RSI) | 35.62 |
Average Volume (30 Days) | 73,681 |
Short Selling Information
Short Interest | 23,350 |
Short Previous Month | 20,211 |
Short % of Shares Out | 0.13% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.32 |
Income Statement
In the last 12 months, MDxHealth had revenue of $70.19 million and -$43.10 million in losses. Loss per share was -$16.60.
Revenue | 70.19M |
Gross Profit | 43.93M |
Operating Income | -27.33M |
Pretax Income | -43.10M |
Net Income | -43.10M |
EBITDA | -20.47M |
EBIT | -27.33M |
Loss Per Share | -$16.60 |
Balance Sheet
The company has $22.38 million in cash and $107.42 million in debt, giving a net cash position of -$85.04 million or -$3.12 per share.
Cash & Cash Equivalents | 22.38M |
Total Debt | 107.42M |
Net Cash | -85.04M |
Net Cash Per Share | -$3.12 |
Equity / Book Value | 7.21M |
Book Value Per Share | 0.26 |
Working Capital | 18.64M |
Cash Flow
In the last 12 months, operating cash flow was -$21.50 million and capital expenditures -$2.75 million, giving a free cash flow of -$24.24 million.
Operating Cash Flow | -21.50M |
Capital Expenditures | -2.75M |
Free Cash Flow | -24.24M |
FCF Per Share | -$8.97 |
Margins
Gross margin is 62.58%, with operating and profit margins of -38.93% and -61.40%.
Gross Margin | 62.58% |
Operating Margin | -38.93% |
Pretax Margin | -61.40% |
Profit Margin | -61.40% |
EBITDA Margin | -29.16% |
EBIT Margin | -38.93% |
FCF Margin | -34.54% |
Dividends & Yields
MDxHealth does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -73.36% |
Shareholder Yield | -73.36% |
Earnings Yield | -60.98% |
FCF Yield | -34.30% |
Analyst Forecast
The average price target for MDxHealth is $7.33, which is 183.01% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $7.33 |
Price Target Difference | 183.01% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 16.65% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 14, 2023. It was a reverse split with a ratio of 1:10.
Last Split Date | Nov 14, 2023 |
Split Type | Reverse |
Split Ratio | 1:10 |
Scores
MDxHealth has an Altman Z-Score of -3.23 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.23 |
Piotroski F-Score | 4 |